Track 1

High Treatment Satisfaction, Natural Looking Results, and Improved Appearance-Related Psychosocial Impact from TrenibotulinumtoxinE Treatment for Glabellar Lines: Pooled Patient Reported Outcomes from 2 Pivotal Phase 3 Trials

Speaker(s)

• 

  Terrence Keaney, MD

  Founder and Director
  SkinDC